Blogs
May 19, 2026
James Montier's Modified C-Score is a six-variable forensic detector for accounting manipulation. We decode all six variables, contrast a disciplined manufacturer with a generic red-flag profile, and show how Titan Biotech FY25's audited numbers score 0/6 — an educational illustration only, not a buy/sell recommendation.
May 19, 2026
Tom Russo's Capacity to Suffer concept names the rarest corporate trait: management willingness to depress today's reported earnings to fund tomorrow's moat. Illustrated with Titan Biotech FY25 audited markers.
May 18, 2026
Pronin, Lin & Ross's 2002 Stanford research on the meta-bias that hides every other cognitive error — why education makes the blind spot worse, the SEBI F&O data that shows ₹1.81 lakh crore of Indian retail losses for what they really are, the six external-structure counter-measures, and how Titan Biotech's FY25 governance architecture (4 of 11 independent directors, 14 board meetings, CFO/OP at 103%, contingent liabilities down 39.7%) illustrates the institutional version of Munger's iron prescription.
May 18, 2026
How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.
